For the Inventor, By the Inventor

Enter inventor name

Boulder, CO, United States of America

Daniel H Doherty

USPTO Granted Patents = 27 (Patent Applications = 3)

CIPO Patents = 2

EPO Patents = 4 (Patent Applications = 3)

Average Co-Inventor Count = 3.4

ph-index = 11

Forward Citations = 513(Granted Patents)

Company Filing History:

Bolder Biotechnology, Inc.

Dsm IP Assets B.v.

4. 2 out of 3,288

Monsanto Company

5. 2 out of 191

Seikagaku Corporation

Getty Scientific Development Company

Baxter Biotech Technology Sarl

8. 1 out of 630

William Marsh Rice University

9. 1 out of 124

Martek Biosciences Corporation

10. 1 out of 59

Cp Kelco U.s., Inc.

11. 1 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 1996-2015

where 'Filed Patents' based on already Granted Patents

27 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 9175293 - Compositions and methods for bacterial and genetically modified microorganism production of chondroitin (2015-11-03),

2. 8932828 - Method for preparing recombinant granulocyte colony stimulating factor cysteine muteins (2015-01-13),

3. 8859855 - Chimeric PUFA polyketide synthase systems and uses thereof (2014-10-14),

4. 8697398 - Compositions and methods for bacterial production of chondroitin (2014-04-15),

5. 8309796 - Chimeric PUFA polyketide synthase systems and uses thereof (2012-11-13),

6. 8288126 - Methods for making proteins containing free cysteine residues (2012-10-16),

7. 8148500 - Method of preparing cysteine mutants of human recombinant GM-CSF (2012-04-03),

8. 8003772 - Chimeric PUFA polyketide synthase systems and uses thereof (2011-08-23),

9. 7947655 - Methods for making proteins containing free cysteine residues (2011-05-24),

10. 7824669 - In vivo stimulation of peripheral blood progenitor cells by granulocyte-macrophage colony stimulating factor (GM-CSF) cysteine muteins and their PEGylated variants (2010-11-02),

11. 7754855 - Immunoglobulin fusion proteins (2010-07-13),

12. 7306931 - Method for refolding proteins containing free cysteine residues (2007-12-11),

13. 7226758 - Nucleic acids encoding glial cell line-derived neurotrophic factor (GDNF) (2007-06-05),

14. 7153943 - Derivatives of growth hormone and related proteins, and methods of use thereof (2006-12-26),

15. 7049406 - Hemoglobin mutants with increased soluble expression and/or reduced nitric oxide scavenging (2006-05-23),

Title: The Inventor Profile of Daniel H. Doherty

Introduction: Daniel H. Doherty is a renowned inventor based in Boulder, Colorado, known for his groundbreaking contributions to various technological fields.

Latest Patents: Daniel H. Doherty holds several patents in the areas of renewable energy, sustainable materials, and advanced robotics, showcasing his innovative spirit and forward-thinking approach.

Career Highlights: With a career spanning over two decades, Daniel H. Doherty has worked with leading research institutions and tech companies, playing a key role in developing cutting-edge technologies that have revolutionized the industry.

Collaborations: Throughout his career, Daniel H. Doherty has collaborated with top engineers, scientists, and designers, fostering a culture of innovation and creativity that has led to the successful implementation of numerous projects.

Conclusion: Daniel H. Doherty's passion for innovation and his relentless pursuit of excellence have established him as a prominent figure in the world of technology, with his work continuing to inspire future generations of inventors.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…